Compound LawsREAL-TIME LEGAL INTELLIGENCE
Home / Compounds / Ketamine / Wyoming

Is Ketamine Legal in Wyoming? (2026)

Illegal

As of November 12, 2026, Ketamine is illegal to sell (federally scheduled; state law on file reads illegal) in Wyoming. Federally Schedule III; lawful possession and use is by prescription or DEA registration only. Controlling source: Wyo. Stat. 35-7-1018 Schedule III (subsection (c) depressants).

Verified November 12, 2026 (hash check) · confidence: confirmed

Is Ketamine Legal? Every state and federal law

Wyoming Ketamine ban status: ban in force

QuietNo pending legislation, deadlines or enforcement actions on file for Ketamine in Wyoming.
Federal
Federally Schedule III; lawful possession and use is by prescription or DEA registration only (effective 1999-08-12). State-law reading underneath: Illegal.
Rule type
permanent
Tier
Schedule I
Schedule
schedule 3
Effective
2001-07-01

What the record says

Wyo. Stat. 35-7-1018(c)(xiii) lists ketamine, its salts, isomers and salts of isomers in Schedule III, so esketamine (Spravato) is covered. Lawful channels are a valid prescription or practitioner order (35-7-1031(c)), Spravato under the FDA REMS, and compounded ketamine on prescription. No Wyoming rule specific to ketamine clinics or telehealth prescribing of ketamine was found. 2-FDCK and deschloroketamine are not named and Wyoming has no controlled substance analog act. Federally Schedule III (see the federal page).

Controlling language, verbatim

(xiii) Ketamine, its salts, isomers and salts of isomers (some other names for ketamine include ()-2-(2- chlorophenyl)-2-(methylamino)-cyclohexanone);

Source of excerpt

Citations

  1. Wyo. Stat. 35-7-1018 Schedule III (subsection (c) depressants) (Wyoming Legislature (Legislative Service Office), 2026-10-31) PRIMARYOFFICIAL

Where Ketamine stands across the country

LegalRestrictedGray areaIllegalNot yet verified

Among Wyoming’s 6 neighbors, Colorado, Idaho, Montana, Nebraska, South Dakota and Utah are illegal, the same posture as Wyoming.

Open the interactive map · Every compound in Wyoming · Where Ketamine is banned · Embed this map

Federal posture

Federally scheduled or prohibited. Federally Schedule III; lawful possession and use is by prescription or DEA registration only Federal detail

Verbatim law on file for Wyoming

9 instruments on file for this compound’s framework in Wyoming; 1 of 1 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.

W.S. 35-7-1011(d) · Control of substances; federal designationOFFICIAL
Instrument
Control of substances; federal designation
Source
https://wyoleg.gov/statutes/compress/title35.pdf
Retrieved
2026-11-06
Fingerprint
b595d7a8901016b4
(d) If any substance is designated, rescheduled, or
deleted as a controlled substance under federal law the
commissioner shall control the substance under this act in the
same manner as federal law within thirty (30) days after
receiving notice of the change but not later than thirty (30)
days after the first publication of the change in the Federal
Register. Under this subsection, the commissioner shall control
the substance in the same manner as federal law through the
promulgation of an emergency rule, followed by promulgation of a
permanent rule under the Wyoming Administrative Procedure Act.
If the commissioner objects to the designation, rescheduling or
deletion of a substance, the commissioner shall within the same
period required to control the substance publish the reasons for
objection and afford all interested parties an opportunity to be
heard. At the conclusion of the hearing, the commissioner shall
publish his decision which shall be final unless altered by
statute. Upon publication of an objection to designation,
rescheduling or deletion under this act by the commissioner,
control under this act is stayed until the commissioner
publishes his final decision. Any final decision that ultimately
controls the substance under this act in the same manner as
federal law shall be finalized through the promulgation of an
emergency rule, followed by promulgation of a permanent rule
under the Wyoming Administrative Procedure Act.
W.S. 35-7-1014 (Schedule I) · W.S. 35-7-1014 (Schedule I)OFFICIAL
Instrument
W.S. 35-7-1014 (Schedule I)
Source
https://wyoleg.gov/statutes/compress/title35.pdf
Retrieved
2026-10-08
Fingerprint
a08d2e77889180e6
35-7-1014. Substances included in Schedule I. (a) The controlled substances listed in this section are included in Schedule I. Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name or brand name designated, listed in this section. (b) Opiates.-Unless specifically excepted or unless listed in another schedule, any of the following opiates, including the isomers, esters, ethers, salts and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation: (i) Acetylmethadol; (ii) Repealed By Laws 1997, ch. 151, § 2. (iii) Allylprodine; (iv) Alphacetylmethadol (except levo- alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM); (v) Alphameprodine; (vi) Alphamethadol; (vii) Alpha-methylfentanyl (N-[1-(alpha-methylbeta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine); (viii) Benzethidine; (ix) Betacetylmethadol; (x) Betameprodine; (xi) Betamethadol; (xii) Betaprodine; (xiii) Clonitazene; (xiv) Dextromoramide; (xv) Diampromide; (xvi) Diethylthiambutene; (xvii) Difenoxin; (xviii) Dimenoxadol; (xix) Dimepheptanol; (xx) Dimethylthiambutene; (xxi) Dioxaphetyl butyrate; (xxii) Dipipanone; (xxiii) Ethylmethylthiambutene; (xxiv) Etonitazene; (xxv) Etoxeridine; (xxvi) Furethidine; (xxvii) Hydroxypethidine; (xxviii) Ketobemidone; (xxix) Levomoramide; (xxx) Levophenacylmorphan; (xxxi) Morpheridine; (xxxii) Noracymethadol; (xxxiii) Norlevorphanol; (xxxiv) Normethadone; (xxxv) Norpipanone; (xxxvi) Phenadoxone; (xxxvii) Phenampromide; (xxxviii) Phenomorphan; (xxxix) Phenoperidine; (xl) Piritramide; (xli) Proheptazine; (xlii) Properidine; (xliii) Propiram; (xliv) Racemoramide; (xlv) Tilidine; (xlvi) Trimeperidine; (xlvii) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl- 2-phenethyl)-4-piperidinyl]-N-phenylacetamide); (xlviii) Alpha-methylthiofentanyl (N-[1-methyl-2-(2- thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide); (xlix) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2- phenethyl)-4-piperidinyl]-N-phenylpropanamide); (l) Beta-hydroxy-3-methylfentanyl (other name: N-[1- (2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N- phenylpropanamide); (li) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)- 4-piperidyl]-N-phenylpropanamide); (lii) 3-Methylthiofentanyl (N-[3-methyl-1-(2- thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide); (liii) MPPP (1-methyl-4-phenyl-4- propionoxypiperidine); (liv) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1- (2-phenethyl)-4-piperidinyl] propanamide); (lv) PEPAP (1-(-2-phenethyl)-4-phenyl-4- acetoxypiperidine); (lvi) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4- piperidinyl]-propanamide). (c) Opium derivatives.-Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, their salts, isomers and salts of isomers whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation: (i) Acetorphine; (ii) Acetyldihydrocodeine; (iii) Benzylmorphine; (iv) Codeine methylbromide; (v) Codeine-N-Oxide; (vi) Cyprenorphine; (vii) Desomorphine; (viii) Dihydromorphine; (ix) Drotebanol; (x) Etorphine (except hydrochloride salt); (xi) Heroin; (xii) Hydromorphinol; (xiii) Methyldesorphine; (xiv) Methyldihydromorphine; (xv) Morphine methylbromide; (xvi) Morphine methylsulfonate; (xvii) Morphine-N-Oxide; (xviii) Myrophine; (xix) Nicocodeine; (xx) Nicomorphine; (xxi) Normorphine; (xxii) Pholcodine; (xxiii) Thebacon. (d) Hallucinogenic substances.-Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers and salts of isomers whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term "isomer" includes the optical, position and geometric isomers): (i) 4-bromo-2, 5-dimethoxyamphetamine; some trade or other names: 4-bromo-2, 5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2, 5-DMA; (ii) 2, 5-dimethoxyamphetamine; some trade or other names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA; (iii) 4-methoxyamphetamine; some trade or other names: 4-methoxy-alpha-methylphenethylamine; paramethoxy-amphetamine; PMA; (iv) 5-methoxy-3,4-methylenedioxy amphetamine; (v) 4-methyl-2, 5-dimethoxyamphetamine; some trade and other names: 4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; “DOM”; and “STP”; (vi) 3,4-methylenedioxy amphetamine; (vii) 3,4,5-trimethoxy amphetamine; (viii) Bufotenine; some trade and other names: 3-(beta-dimethy-laminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,N-dimethylserotonin; 5-hydroxy-N, N-dimethyltryptamine; mappine; (ix) Diethyltryptamine; some trade and other names: N,N-diethyltryptamine; DET; (x) Dimethyltryptamine; some trade or other names: DMT; (xi) Ibogaine; some trade and other names: 7-ethyl-6,6 beta, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b] indole; tabernanthe iboga; (xii) Lysergic acid diethylamide; (xiii) Marihuana; (xiv) Mescaline; (xv) Parahexyl; some trade or other names; 3-hexyl-1-hydroxy 7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b,d] pyran; synhexyl; (xvi) Peyote; meaning all parts of the plant presently classified botanically as Lophophora Williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture, or preparation of such plant, its seeds or extracts; (xvii) N-ethyl-3-piperidyl benzilate; (xviii) N-methyl-3-piperidyl benzilate; (xix) Psilocybin; (xx) Psilocyn; (xxi) Tetrahydrocannabinols; naturally occurring or synthetic equivalents of the substances contained in the plant or in the resinous extractives of Cannabis, sp. and/or naturally occurring or synthetic substances, derivatives and their isomers with similar chemical structure and pharmacological activity such as the following: delta 1 cis or trans tetrahydrocannabinol and their optical isomers; delta 6 cis or trans tetrahydrocannabinol and their optical isomers; delta 8 cis or trans tetrahydrocannabinol and their optical isomers; delta to the 3, 4 cis or trans tetrahydrocannabinol and its optical isomers. Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions are covered; (xxii) Ethylamine analog of phencyclidine; some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1 phenylcyclohexyl) ethylamine, cyclohexamine, PCE; (xxiii) Pyrrolidine analog of phencyclidine; some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP; (xxiv) Thiophene analog of phencyclidine; some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienyl analog of phencyclidine, TPCP, TCP; (xxv) Alpha-ethyltryptamine; some trade or other names: etryptamine; Monase; A-ethyl-1H-indole-3-ethanamine; 3- (2-aminobutyl) indole; --ET; and AET; (xxvi) 4-Bromo-2,5-dimethoxyphenethylamine; some trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1- aminoethane; alpha-desmethyl DOB; 2C-B, nexus; (xxvii) 2,5-Dimethoxy-4-ethylamphetamine; some trade or other names: DOET; (xxviii) 3,4-Methylenedioxymethamphetamine (MDMA); (xxix) 3,4-Methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA); (xxx) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl- 3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA); (xxxi) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine; some other names: TCPy; (xxxii) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7), its optical isomers, salts and salts of isomers; (xxxiii) Alpha-methyltryptamine; (other name: AMT); (xxxiv) 5-methoxy-N,N-diisopropyltryptamine; (other name: 5-MeO-DIPT), its isomers, salts and salts of isomers; (xxxv) Salvinorin A; (xxxvi) 3,4-Methylenedioxymethcathinone (other names: Methylone); (xxxvii) 3,4–Methylenedioxypyrovalerone (MDPV); (xxxviii) 4–Methylmethcathinone (other names Mephedrone); (xxxix) 3–Methoxymethcathinone; (xl) 3–Fluoromethcathinone; (xli) 4–Fluoromethcathinone; (xlii) Synthetic cannabinoids as follows: (A) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3- (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol; some trade or other names: HU-210; (B) Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)- 6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- tetrahydrobenzo[c]chromen-1-ol; some trade or other names: HU- 211; (C) Any compound structurally derived from 3-(1- napthoyl)indole, 1H-indol-3-yl-(1-naphthyl)methane, 3-(1- napthoyl)pyrrole, 3-(phenylacetyl)indole, 3-(benzoyl)indole or naphthylideneindene by substitution at the nitrogen atom of the indole ring, pyrrole ring or 3-position of the indene ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1- (N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole ring, pyrrole ring or indene ring to any extent, and whether or not substituted in the naphthyl or phenyl ring to any extent; (D) Repealed By Laws 2012, Ch. 29, § 2. (E) Any compound containing a 2-(3- hydroxycyclohexyl)phenol structure with substitution at the 5- position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or not substituted in the cyclohexyl ring to any extent; (F) 2,3-Dihydro-5-methyl-3-(4- morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1- naphthalenylmethanone; some trade or other names: WIN 55,212-2; (G) [(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3- tetramethylcyclopropyl)methanone]; other names: XLR-11; (H) [(1-pentyl-1H-indol-3-yl)(2,2,3,3- tetramethylcyclopropyl)methanone]; other names: UR-144; (J) 1-pentyl-8-quinolinyl ester-1H-indole-3- carboxylic acid; other names: PB-22; (K) 1-(5-fluoropentyl)-8-quinolinyl ester-1H- indole-3-carboxylic acid; other names: 5F-PB-22; (M) 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H- indazole-3-carboxamide; other names: AKB48; (N) N-((3s,5s,7s)-adamantan-1-yl)-1-(5- fluoropentyl)1H-indazole-3-carboxamide; other names: 5F-AKB48; (O) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4- fluorobenzyl)-1H-indazole-3-carboxamide; other names: AB- FUBINACA; (P) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- pentyl-1H-indazole-3-carboxamide; other names: ADB-PINACA; (Q) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1- pentyl-1H-indazole-3-carboxamide; other names: AB-PINACA; (R) N-(1-amino-3,3-dimethyl-1-oxobutan-2yl)-1- (5-fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-ADB- PINACA; (S) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5- fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-AB- PINACA; (T) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cycl ohexylmethyl)-1H-indazole-3-carboxamide; other names: AB– CHMINACA; (U) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphtha len-1-yl)methanone; other names: THJ–2201; (W) 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester; other names: BB-22. (xliii) 2-(2,5-dimethoxy-4-ethylphenyl)ethanamine; other names: 2C-E; (xliv) 2-(2,5-dimethoxy-4-methylphenyl)ethanamine; other names: 2C-D; (xlv) 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine; other names: 2C-C; (xlvi) 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine; other names: 2C-I; (xlvii) 2-[4-(ethylthio)-2,5- dimethoxyphenyl]ethanamine; other names: 2C-T-2; (xlviii) 2-[4-(isopropylthio)-2,5- dimethoxyphenyl]ethanamine; other names: 2C-T-4; (xlix) 2-(2,5-dimethoxyphenyl)ethanamine; other names: 2C-H; (l) 2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine; other names: 2C-N; (li) 2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine; other names: 2C-P; (lii) 4-bromo-2,5-dimethoxy-N-[(2- methoxyphenyl)methyl]-benzeneethanamine; other names: 25B-NBOMe; (liii) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine; other names: 25C-NBOMe or 2C-C-NBOMe; (liv) 4-iodo-2,5-dimethoxy-N-[(2- methoxyphenyl)methyl]-benzeneethanamine; other names: 25I-NBOMe; (lv) 3,4-methylenedioxy-N-ethylcathinone; (other names: ethylone). (e) Depressants.-Unless specifically excepted or unless listed in another schedule, any material compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation: (i) Mecloqualone; (ii) Methaqualone; (iii) Gamma-hydroxybutyric (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate). (f) Stimulants.-Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its optical, positional, and geometric isomers, salts and salts of isomers: (i) Fenethylline; (ii) N-ethylamphetamine; (iii) Aminorex; some other names: aminoxaphen; 2- amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenyl-2- oxazolamine; (iv) Cathinone; some trade or other names: 2-amino-1- phenyl-1-propanone, alpha-aminopropiophenone, 2- aminopropiophenone, and norephedrone; (v) Methcathinone; some other names: 2-(methylamino)- propiophenone; alpha-(methylamino)propiophenone; 2- (methylamino)-1-phenylpropan-1-one; alpha-N- methylaminopropiophenone; monomethylpropion; ephedrone; N- methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers; (vi) (()Cis-4-methylaminorex ((()cis-4,5-dihydro-4- methyl-5-phenyl-2-oxazolamine); (vii) N,N-dimethylamphetamine (also known as N,N- alpha-trimethyl-benzeneethanamine; N,N-alpha- trimethylphenethylamine); (viii) N-Benzylpiperazine; (some other names: BZP, 1- benzylpiperazine), its optical isomers, salts and salts of isomers; (ix) 4-methyl-N-ethylcathinone; other names: 4-MEC; 2-(ethylamino)-1-(4-methylphenyl)propan-1-one; (x) 4-methyl-alpha-pyrrolidinopropiophenone; other names: 4-MePPP; MePPP; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one; (xi) Alpha-pyrrolidinopentiophenone; other names: alpha-PVP; alpha-pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1-yl)pent an-1-one; (xii) Butylone; other names: bk-MBDB; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one; (xiii) Pentedrone; other names: alpha-methylaminovalerophenone; 2-(methylamino)-1-phenylpentan-1-one; (xiv) Pentylone; other names: bk-MBDP; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one; (xv) Naphyrone; other names: naphthylpyrovalerone; 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one; (xvi) Alpha-pyrrolidinobutiophenone; other names: alpha-PBP; 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one. (g) Temporary listing of substances subject to emergency scheduling. Any material, compound, mixture or preparation which contains any quantity of the following substances: (i) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical isomers, salts and salts of isomers; (ii) N-[1-(2-thienyl)methyl-4-piperidyl]-N- phenylpropanamide (thenylfentanyl), its optical isomers, salts and salts of isomers.
W.S. 35-7-1014(d) · Substances included in Schedule I, hallucinogenic substancesOFFICIAL
Instrument
Substances included in Schedule I, hallucinogenic substances
Source
https://wyoleg.gov/statutes/compress/title35.pdf
Retrieved
2026-11-06
Fingerprint
d3cddb8dde7ff1ae
(d) Hallucinogenic substances.-Unless specifically
excepted or unless listed in another schedule, any material,
compound, mixture or preparation which contains any quantity of
the following hallucinogenic substances, their salts, isomers
and salts of isomers whenever the existence of these salts,
isomers and salts of isomers is possible within the specific
chemical designation (for purposes of this paragraph only, the
term "isomer" includes the optical, position and geometric
isomers):

          (i) 4-bromo-2, 5-dimethoxyamphetamine; some trade or
other names:   4-bromo-2,
5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2, 5-DMA;

          (ii) 2, 5-dimethoxyamphetamine; some trade or other
names:   2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA;

          (iii) 4-methoxyamphetamine; some trade or other
names:   4-methoxy-alpha-methylphenethylamine;
paramethoxy-amphetamine; PMA;

         (iv)    5-methoxy-3,4-methylenedioxy amphetamine;

          (v) 4-methyl-2, 5-dimethoxyamphetamine; some trade
and other names:
4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; “DOM”; and
“STP”;

         (vi)    3,4-methylenedioxy amphetamine;

         (vii)    3,4,5-trimethoxy amphetamine;

          (viii) Bufotenine; some trade and other names:
3-(beta-dimethy-laminoethyl)-5-hydroxyindole;
3-(2-dimethylaminoethyl)-5-indolol; N,N-dimethylserotonin;
5-hydroxy-N, N-dimethyltryptamine; mappine;

          (ix) Diethyltryptamine; some trade and other names:
N,N-diethyltryptamine; DET;
         (x)    Dimethyltryptamine; some trade or other names:
DMT;

          (xi) Ibogaine; some trade and other names:
7-ethyl-6,6 beta, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6,
9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b] indole;
tabernanthe iboga;

         (xii)    Lysergic acid diethylamide;

         (xiii)    Marihuana;

         (xiv)    Mescaline;

          (xv) Parahexyl; some trade or other names;
3-hexyl-1-hydroxy 7, 8, 9, 10-tetrahydro-6, 6,
9-trimethyl-6H-dibenzo [b,d] pyran; synhexyl;

          (xvi) Peyote; meaning all parts of the plant
presently classified botanically as Lophophora Williamsii
Lemaire, whether growing or not, the seeds thereof, any extract
from any part of such plant, and every compound, manufacture,
salts, derivative, mixture, or preparation of such plant, its
seeds or extracts;

         (xvii)    N-ethyl-3-piperidyl benzilate;

         (xviii)    N-methyl-3-piperidyl benzilate;

         (xix)    Psilocybin;

         (xx)    Psilocyn;

          (xxi) Tetrahydrocannabinols; naturally occurring or
synthetic equivalents of the substances contained in the plant
or in the resinous extractives of Cannabis, sp. and/or naturally
occurring or synthetic substances, derivatives and their isomers
with similar chemical structure and pharmacological activity
such as the following: delta 1 cis or trans
tetrahydrocannabinol and their optical isomers; delta 6 cis or
trans tetrahydrocannabinol and their optical isomers; delta 8
cis or trans tetrahydrocannabinol and their optical isomers;
delta to the 3, 4 cis or trans tetrahydrocannabinol and its
optical isomers. Since nomenclature of these substances is not
internationally standardized, compounds of these structures,
regardless of numerical designation of atomic positions are
covered;
          (xxii) Ethylamine analog of phencyclidine; some trade
or other names:   N-ethyl-1-phenylcyclohexylamine,
(1-phenylcyclohexyl) ethylamine, N-(1 phenylcyclohexyl)
ethylamine, cyclohexamine, PCE;

          (xxiii) Pyrrolidine analog of phencyclidine; some
trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy,
PHP;

          (xxiv) Thiophene analog of phencyclidine; some trade
or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine,
2-thienyl analog of phencyclidine, TPCP, TCP;

          (xxv) Alpha-ethyltryptamine; some trade or other
names: etryptamine; Monase; A-ethyl-1H-indole-3-ethanamine; 3-
(2-aminobutyl) indole; --ET; and AET;

          (xxvi) 4-Bromo-2,5-dimethoxyphenethylamine; some
trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-
aminoethane; alpha-desmethyl DOB; 2C-B, nexus;

          (xxvii) 2,5-Dimethoxy-4-ethylamphetamine; some trade
or other names: DOET;

         (xxviii)   3,4-Methylenedioxymethamphetamine (MDMA);

          (xxix) 3,4-Methylenedioxy-N-ethylamphetamine (also
known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine,
N-ethyl MDA, MDE, MDEA);

          (xxx) N-hydroxy-3,4-methylenedioxyamphetamine (also
known as N-hydroxy-alpha-methyl-
3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA);

          (xxxi) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine; some
other names: TCPy;

          (xxxii) 2,5-dimethoxy-4-(n)-propylthiophenethylamine
(other name: 2C-T-7), its optical isomers, salts and salts of
isomers;

         (xxxiii)   Alpha-methyltryptamine; (other name: AMT);

          (xxxiv) 5-methoxy-N,N-diisopropyltryptamine; (other
name: 5-MeO-DIPT), its isomers, salts and salts of isomers;
         (xxxv)       Salvinorin A;

          (xxxvi)     3,4-Methylenedioxymethcathinone (other names:
Methylone);

         (xxxvii)      3,4–Methylenedioxypyrovalerone (MDPV);

          (xxxviii)     4–Methylmethcathinone (other names
Mephedrone);

         (xxxix)      3–Methoxymethcathinone;

         (xl)    3–Fluoromethcathinone;

         (xli)    4–Fluoromethcathinone;

         (xlii)       Synthetic cannabinoids as follows:

               (A) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
some trade or other names: HU-210;

               (B) Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-
6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-
tetrahydrobenzo[c]chromen-1-ol; some trade or other names: HU-
211;

               (C) Any compound structurally derived from 3-(1-
napthoyl)indole, 1H-indol-3-yl-(1-naphthyl)methane, 3-(1-
napthoyl)pyrrole, 3-(phenylacetyl)indole, 3-(benzoyl)indole or
naphthylideneindene by substitution at the nitrogen atom of the
indole ring, pyrrole ring or 3-position of the indene ring by
alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-
(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl,
whether or not further substituted in the indole ring, pyrrole
ring or indene ring to any extent, and whether or not
substituted in the naphthyl or phenyl ring to any extent;

                (D)    Repealed By Laws 2012, Ch. 29, § 2.

               (E) Any compound containing a 2-(3-
hydroxycyclohexyl)phenol structure with substitution at the 5-
position of the phenolic ring by an alkyl, haloalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-
piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or
not substituted in the cyclohexyl ring to any extent;
               (F) 2,3-Dihydro-5-methyl-3-(4-
morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-
naphthalenylmethanone; some trade or other names: WIN 55,212-2;

               (G) [(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone]; other names: XLR-11;

               (H) [(1-pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone]; other names: UR-144;

               (J) 1-pentyl-8-quinolinyl ester-1H-indole-3-
carboxylic acid; other names: PB-22;

               (K) 1-(5-fluoropentyl)-8-quinolinyl ester-1H-
indole-3-carboxylic acid; other names: 5F-PB-22;

               (M) 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-
indazole-3-carboxamide; other names: AKB48;

               (N) N-((3s,5s,7s)-adamantan-1-yl)-1-(5-
fluoropentyl)1H-indazole-3-carboxamide; other names: 5F-AKB48;

               (O) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-
fluorobenzyl)-1H-indazole-3-carboxamide; other names: AB-
FUBINACA;

               (P) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-
pentyl-1H-indazole-3-carboxamide; other names: ADB-PINACA;

               (Q) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-
pentyl-1H-indazole-3-carboxamide; other names: AB-PINACA;

               (R) N-(1-amino-3,3-dimethyl-1-oxobutan-2yl)-1-
(5-fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-ADB-
PINACA;

               (S) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-
fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-AB-
PINACA;

               (T) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cycl
ohexylmethyl)-1H-indazole-3-carboxamide; other names: AB–
CHMINACA;

               (U) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphtha
len-1-yl)methanone; other names: THJ–2201;
               (W) 1-(cyclohexylmethyl)-1H-indole-3-carboxylic
acid 8-quinolinyl ester; other names: BB-22.

          (xliii) 2-(2,5-dimethoxy-4-ethylphenyl)ethanamine;
other names: 2C-E;

          (xliv) 2-(2,5-dimethoxy-4-methylphenyl)ethanamine;
other names: 2C-D;

          (xlv) 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine;
other names: 2C-C;

          (xlvi) 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine;
other names: 2C-I;

          (xlvii) 2-[4-(ethylthio)-2,5-
dimethoxyphenyl]ethanamine; other names: 2C-T-2;

          (xlviii) 2-[4-(isopropylthio)-2,5-
dimethoxyphenyl]ethanamine; other names: 2C-T-4;

          (xlix)   2-(2,5-dimethoxyphenyl)ethanamine; other
names: 2C-H;

          (l)   2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine; other
names: 2C-N;

          (li) 2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine;
other names: 2C-P;

          (lii) 4-bromo-2,5-dimethoxy-N-[(2-
methoxyphenyl)methyl]-benzeneethanamine; other names: 25B-NBOMe;

          (liii) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-
methoxybenzyl)ethanamine; other names: 25C-NBOMe or 2C-C-NBOMe;

          (liv) 4-iodo-2,5-dimethoxy-N-[(2-
methoxyphenyl)methyl]-benzeneethanamine; other names: 25I-NBOMe;

          (lv) 3,4-methylenedioxy-N-ethylcathinone; (other
names: ethylone).
Show 6 more laws on file
W.S. 6-9-203 · Unlawful use of toxic substances; penaltyOFFICIAL
Instrument
Unlawful use of toxic substances; penalty
Source
https://wyoleg.gov/statutes/compress/title06.pdf
Retrieved
2026-10-31
Fingerprint
38a74e45d509fb38
6-9-203.     Unlawful use of toxic substances; penalty.

     (a) A person commits the offense of unlawful use of a
toxic substance if he inhales or ingests or possesses with the
purpose to inhale or ingest, for the purpose of altering his
mental or physical state, any toxic substance that is not
manufactured for human consumption or inhalation.

     (b)    As used in this section “toxic substance” means:

          (i) Volatile solvents including, but not limited to,
paint thinner, gasoline, correction fluid, felt-tip markers,
nail polish remover and glue;
          (ii) Aerosols containing propellants and solvents
such as toluene including, but not limited to, spray paint,
deodorant, hair products, cooking products and fabric
protectors;

          (iii) Gases including, but not limited to, butane,
refrigerants and organic hydrocarbons not created for human
ingestion, inhalation or injection; and

          (iv) Nitrates including, but not limited to
cyclohexyl nitrate, amyl nitrate and butyl nitrate.

     (c) The provisions of subsection (a) of this section do
not apply to a bona fide institution of higher education
conducting research with human volunteers pursuant to guidelines
adopted by the institution or any federal or state agency.

     (d) A violation of this section is punishable by
imprisonment for not more than six (6) months, a fine of not
more than seven hundred fifty dollars ($750.00), or both.
Wyo. Stat. § 35-7-1002(a)(iv)-(v) · Definitions: controlled substance; counterfeit substanceOFFICIAL
Instrument
Definitions: controlled substance; counterfeit substance
Source
https://wyoleg.gov/statutes/compress/title35.pdf
Retrieved
2026-10-29
Fingerprint
8bb1771a410fd0cb
(iv)  “Controlled substance” means a drug, substance,
or immediate precursor in schedules I through V of article III;

(v)  “Counterfeit substance” means a controlled

substance which, or the container or labeling of which, without
authorization, bears the trademark, trade name, or other
identifying mark, imprint, number or device, or any likeness
thereof, of a manufacturer, distributor, or dispenser other than
the person who in fact manufactured, distributed, or dispensed
the substance;
Wyo. Stat. § 35-7-1014(d) (Schedule I hallucinogens); § 35-7-1002(a)(iv) (controlled substance definition) · Schedule I hallucinogenic substances; controlled substance definitionOFFICIAL
Instrument
Schedule I hallucinogenic substances; controlled substance definition
Source
https://wyoleg.gov/statutes/compress/title35.pdf
Retrieved
2026-10-29
Fingerprint
5614ccd07cd8d383
(d)  Hallucinogenic substances.-Unless specifically
excepted or unless listed in another schedule, any material,
compound, mixture or preparation which contains any quantity of
the following hallucinogenic substances, their salts, isomers
and salts of isomers whenever the existence of these salts,
isomers and salts of isomers is possible within the specific
chemical designation (for purposes of this paragraph only, the
term "isomer" includes the optical, position and geometric
isomers):

(i)  4-bromo-2, 5-dimethoxyamphetamine; some trade or

other names:   4-bromo-2,
5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2, 5-DMA;

(ii)  2, 5-dimethoxyamphetamine; some trade or other

names:   2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA;

(iii)  4-methoxyamphetamine; some trade or other

names:   4-methoxy-alpha-methylphenethylamine;
paramethoxy-amphetamine; PMA;

(iv)  5-methoxy-3,4-methylenedioxy amphetamine;

(v)  4-methyl-2, 5-dimethoxyamphetamine; some trade

and other names:
4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; “DOM”; and
“STP”;

(vi)  3,4-methylenedioxy amphetamine;

(vii)  3,4,5-trimethoxy amphetamine;

(viii)  Bufotenine; some trade and other names:

3-(beta-dimethy-laminoethyl)-5-hydroxyindole;
3-(2-dimethylaminoethyl)-5-indolol; N,N-dimethylserotonin;
5-hydroxy-N, N-dimethyltryptamine; mappine;

(ix)  Diethyltryptamine; some trade and other names:

N,N-diethyltryptamine; DET;

(x)  Dimethyltryptamine; some trade or other names:

DMT;

(xi)  Ibogaine; some trade and other names:

7-ethyl-6,6 beta, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6,
9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b] indole;
tabernanthe iboga;

(xii)  Lysergic acid diethylamide;

(xiii)  Marihuana;

(xiv)  Mescaline;

(xv)  Parahexyl; some  trade or other names;

3-hexyl-1-hydroxy 7, 8, 9, 10-tetrahydro-6, 6,
9-trimethyl-6H-dibenzo [b,d] pyran; synhexyl;

(xvi)  Peyote; meaning all parts of the plant

presently classified botanically as Lophophora Williamsii
Lemaire, whether growing or not, the seeds thereof, any extract
from any part of such plant, and every compound, manufacture,
salts, derivative, mixture, or preparation of such plant, its
seeds or extracts;

(xvii)  N-ethyl-3-piperidyl benzilate;

(xviii)  N-methyl-3-piperidyl benzilate;

(xix)  Psilocybin;

(xx)  Psilocyn;

(xxi)  Tetrahydrocannabinols; naturally occurring or
synthetic equivalents of the substances contained in the plant
or in the resinous extractives of Cannabis, sp. and/or naturally
occurring or synthetic substances, derivatives and their isomers
with similar chemical structure and pharmacological activity
such as the following: delta  1 cis or trans
tetrahydrocannabinol and their optical isomers; delta 6 cis or
trans tetrahydrocannabinol and their optical isomers; delta 8
cis or trans tetrahydrocannabinol and their optical isomers;
delta to the 3, 4 cis or trans tetrahydrocannabinol and its
optical isomers. Since nomenclature of these substances is not
internationally standardized, compounds of these structures,
regardless of numerical designation of atomic positions are
covered;

(xxii)  Ethylamine analog of phencyclidine; some trade

or other names:   N-ethyl-1-phenylcyclohexylamine,
(1-phenylcyclohexyl) ethylamine, N-(1 phenylcyclohexyl)
ethylamine, cyclohexamine, PCE;

(xxiii)  Pyrrolidine analog of phencyclidine; some

trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy,
PHP;

(xxiv)  Thiophene analog of phencyclidine; some trade

or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine,
2-thienyl analog of phencyclidine, TPCP, TCP;

(xxv)  Alpha-ethyltryptamine; some trade or other

names: etryptamine; Monase; A-ethyl-1H-indole-3-ethanamine; 3-
(2-aminobutyl) indole; --ET; and AET;

(xxvi)  4-Bromo-2,5-dimethoxyphenethylamine; some

trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-
aminoethane; alpha-desmethyl DOB; 2C-B, nexus;

(xxvii)  2,5-Dimethoxy-4-ethylamphetamine; some trade

or other names: DOET;

(xxviii)  3,4-Methylenedioxymethamphetamine (MDMA);

(xxix)  3,4-Methylenedioxy-N-ethylamphetamine (also

known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine,
N-ethyl MDA, MDE, MDEA);

(xxx)  N-hydroxy-3,4-methylenedioxyamphetamine (also

known as N-hydroxy-alpha-methyl-
3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA);

(xxxi)  1-[1-(2-thienyl)cyclohexyl]pyrrolidine; some

other names: TCPy;

(xxxii)  2,5-dimethoxy-4-(n)-propylthiophenethylamine

(other name:  2C-T-7), its optical isomers, salts and salts of
isomers;

(xxxiii)  Alpha-methyltryptamine; (other name: AMT);

(xxxiv)  5-methoxy-N,N-diisopropyltryptamine; (other

name: 5-MeO-DIPT), its isomers, salts and salts of isomers;

(xxxv)  Salvinorin A;

(xxxvi)  3,4-Methylenedioxymethcathinone (other names:

Methylone);

(xxxvii)  3,4–Methylenedioxypyrovalerone (MDPV);

(xxxviii)  4–Methylmethcathinone (other names

Mephedrone);

(xxxix)  3–Methoxymethcathinone;

(xl)  3–Fluoromethcathinone;

(xli)  4–Fluoromethcathinone;

(xlii)  Synthetic cannabinoids as follows:

(A)  (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-

(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
some trade or other names: HU-210;

(B)  Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-

6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-
tetrahydrobenzo[c]chromen-1-ol; some trade or other names: HU-
211;

(C)  Any compound structurally derived from 3-(1-

napthoyl)indole, 1H-indol-3-yl-(1-naphthyl)methane, 3-(1-
napthoyl)pyrrole, 3-(phenylacetyl)indole, 3-(benzoyl)indole or
naphthylideneindene by substitution at the nitrogen atom of the
indole ring, pyrrole ring or 3-position of the indene ring by
alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-
(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl,
whether or not further substituted in the indole ring, pyrrole
ring or indene ring to any extent, and whether or not
substituted in the naphthyl or phenyl ring to any extent;

(D)  Repealed By Laws 2012, Ch. 29, § 2.

(E)  Any compound containing a 2-(3-

hydroxycyclohexyl)phenol structure with substitution at the 5-
position of the phenolic ring by an alkyl, haloalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-
piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or
not substituted in the cyclohexyl ring to any extent;

(F)  2,3-Dihydro-5-methyl-3-(4-

morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-
naphthalenylmethanone; some trade or other names: WIN 55,212-2;

tetramethylcyclopropyl)methanone]; other names: XLR-11;

(G)  [(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-

tetramethylcyclopropyl)methanone]; other names: UR-144;

(H)  [(1-pentyl-1H-indol-3-yl)(2,2,3,3-

carboxylic acid; other names: PB-22;

(J)  1-pentyl-8-quinolinyl ester-1H-indole-3-

indole-3-carboxylic acid; other names: 5F-PB-22;

(K)  1-(5-fluoropentyl)-8-quinolinyl ester-1H-

indazole-3-carboxamide; other names: AKB48;

(M)  1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-

fluoropentyl)1H-indazole-3-carboxamide; other names: 5F-AKB48;

(N)  N-((3s,5s,7s)-adamantan-1-yl)-1-(5-

(O)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-

fluorobenzyl)-1H-indazole-3-carboxamide; other names: AB-
FUBINACA;

pentyl-1H-indazole-3-carboxamide; other names: ADB-PINACA;

(P)  N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-

pentyl-1H-indazole-3-carboxamide; other names: AB-PINACA;

(Q)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-

(R)  N-(1-amino-3,3-dimethyl-1-oxobutan-2yl)-1-

(5-fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-ADB-
PINACA;

(S)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-

fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-AB-
PINACA;

(T)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cycl

ohexylmethyl)-1H-indazole-3-carboxamide; other names: AB–
CHMINACA;

len-1-yl)methanone; other names: THJ–2201;

(U)  [1-(5-fluoropentyl)-1H-indazol-3-yl](naphtha

acid 8-quinolinyl ester; other names: BB-22.

(W)  1-(cyclohexylmethyl)-1H-indole-3-carboxylic

(xliii)  2-(2,5-dimethoxy-4-ethylphenyl)ethanamine;

other names: 2C-E;

(xliv)  2-(2,5-dimethoxy-4-methylphenyl)ethanamine;

other names: 2C-D;

(xlv)  2-(4-chloro-2,5-dimethoxyphenyl)ethanamine;

other names: 2C-C;

(xlvi)  2-(4-iodo-2,5-dimethoxyphenyl)ethanamine;

other names: 2C-I;

(xlvii)  2-[4-(ethylthio)-2,5-
dimethoxyphenyl]ethanamine; other names: 2C-T-2;

(xlviii)  2-[4-(isopropylthio)-2,5-

dimethoxyphenyl]ethanamine; other names: 2C-T-4;

(xlix)  2-(2,5-dimethoxyphenyl)ethanamine; other

names: 2C-H;

(l)  2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine; other

names: 2C-N;

(li)  2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine;

other names: 2C-P;

(lii)  4-bromo-2,5-dimethoxy-N-[(2-

methoxyphenyl)methyl]-benzeneethanamine; other names: 25B-NBOMe;

(liii)  2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-

methoxybenzyl)ethanamine; other names: 25C-NBOMe or 2C-C-NBOMe;

(liv)  4-iodo-2,5-dimethoxy-N-[(2-

methoxyphenyl)methyl]-benzeneethanamine; other names: 25I-NBOMe;

(lv)  3,4-methylenedioxy-N-ethylcathinone; (other

names: ethylone).

(iv)  “Controlled substance” means a drug, substance,
or immediate precursor in schedules I through V of article III;
Wyo. Stat. 35-7-1014(a), (d) · Schedule I; hallucinogenic substancesOFFICIAL
Instrument
Schedule I; hallucinogenic substances
Source
https://wyoleg.gov/statutes/compress/title35.pdf
Retrieved
2026-10-31
Fingerprint
d5403f4476716250
35-7-1014.    Substances included in Schedule I.
     (a) The controlled substances listed in this section are
included in Schedule I. Schedule I shall consist of the drugs
and other substances, by whatever official name, common or usual
name, chemical name or brand name designated, listed in this
section.
(d) Hallucinogenic substances.-Unless specifically
excepted or unless listed in another schedule, any material,
compound, mixture or preparation which contains any quantity of
the following hallucinogenic substances, their salts, isomers
and salts of isomers whenever the existence of these salts,
isomers and salts of isomers is possible within the specific
chemical designation (for purposes of this paragraph only, the
term "isomer" includes the optical, position and geometric
isomers):

          (i) 4-bromo-2, 5-dimethoxyamphetamine; some trade or
other names:   4-bromo-2,
5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2, 5-DMA;

          (ii) 2, 5-dimethoxyamphetamine; some trade or other
names:   2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA;

          (iii) 4-methoxyamphetamine; some trade or other
names:   4-methoxy-alpha-methylphenethylamine;
paramethoxy-amphetamine; PMA;

         (iv)    5-methoxy-3,4-methylenedioxy amphetamine;

          (v) 4-methyl-2, 5-dimethoxyamphetamine; some trade
and other names:
4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; “DOM”; and
“STP”;

         (vi)    3,4-methylenedioxy amphetamine;

         (vii)    3,4,5-trimethoxy amphetamine;

          (viii) Bufotenine; some trade and other names:
3-(beta-dimethy-laminoethyl)-5-hydroxyindole;
3-(2-dimethylaminoethyl)-5-indolol; N,N-dimethylserotonin;
5-hydroxy-N, N-dimethyltryptamine; mappine;

          (ix) Diethyltryptamine; some trade and other names:
N,N-diethyltryptamine; DET;
         (x)    Dimethyltryptamine; some trade or other names:
DMT;

          (xi) Ibogaine; some trade and other names:
7-ethyl-6,6 beta, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6,
9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b] indole;
tabernanthe iboga;

         (xii)    Lysergic acid diethylamide;

         (xiii)    Marihuana;

         (xiv)    Mescaline;

          (xv) Parahexyl; some trade or other names;
3-hexyl-1-hydroxy 7, 8, 9, 10-tetrahydro-6, 6,
9-trimethyl-6H-dibenzo [b,d] pyran; synhexyl;

          (xvi) Peyote; meaning all parts of the plant
presently classified botanically as Lophophora Williamsii
Lemaire, whether growing or not, the seeds thereof, any extract
from any part of such plant, and every compound, manufacture,
salts, derivative, mixture, or preparation of such plant, its
seeds or extracts;

         (xvii)    N-ethyl-3-piperidyl benzilate;

         (xviii)    N-methyl-3-piperidyl benzilate;

         (xix)    Psilocybin;

         (xx)    Psilocyn;

          (xxi) Tetrahydrocannabinols; naturally occurring or
synthetic equivalents of the substances contained in the plant
or in the resinous extractives of Cannabis, sp. and/or naturally
occurring or synthetic substances, derivatives and their isomers
with similar chemical structure and pharmacological activity
such as the following: delta 1 cis or trans
tetrahydrocannabinol and their optical isomers; delta 6 cis or
trans tetrahydrocannabinol and their optical isomers; delta 8
cis or trans tetrahydrocannabinol and their optical isomers;
delta to the 3, 4 cis or trans tetrahydrocannabinol and its
optical isomers. Since nomenclature of these substances is not
internationally standardized, compounds of these structures,
regardless of numerical designation of atomic positions are
covered;
          (xxii) Ethylamine analog of phencyclidine; some trade
or other names:   N-ethyl-1-phenylcyclohexylamine,
(1-phenylcyclohexyl) ethylamine, N-(1 phenylcyclohexyl)
ethylamine, cyclohexamine, PCE;

          (xxiii) Pyrrolidine analog of phencyclidine; some
trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy,
PHP;

          (xxiv) Thiophene analog of phencyclidine; some trade
or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine,
2-thienyl analog of phencyclidine, TPCP, TCP;

          (xxv) Alpha-ethyltryptamine; some trade or other
names: etryptamine; Monase; A-ethyl-1H-indole-3-ethanamine; 3-
(2-aminobutyl) indole; --ET; and AET;

          (xxvi) 4-Bromo-2,5-dimethoxyphenethylamine; some
trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-
aminoethane; alpha-desmethyl DOB; 2C-B, nexus;

          (xxvii) 2,5-Dimethoxy-4-ethylamphetamine; some trade
or other names: DOET;

         (xxviii)   3,4-Methylenedioxymethamphetamine (MDMA);

          (xxix) 3,4-Methylenedioxy-N-ethylamphetamine (also
known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine,
N-ethyl MDA, MDE, MDEA);

          (xxx) N-hydroxy-3,4-methylenedioxyamphetamine (also
known as N-hydroxy-alpha-methyl-
3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA);

          (xxxi) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine; some
other names: TCPy;

          (xxxii) 2,5-dimethoxy-4-(n)-propylthiophenethylamine
(other name: 2C-T-7), its optical isomers, salts and salts of
isomers;

         (xxxiii)   Alpha-methyltryptamine; (other name: AMT);

          (xxxiv) 5-methoxy-N,N-diisopropyltryptamine; (other
name: 5-MeO-DIPT), its isomers, salts and salts of isomers;
         (xxxv)       Salvinorin A;

          (xxxvi)     3,4-Methylenedioxymethcathinone (other names:
Methylone);

         (xxxvii)      3,4–Methylenedioxypyrovalerone (MDPV);

          (xxxviii)     4–Methylmethcathinone (other names
Mephedrone);

         (xxxix)      3–Methoxymethcathinone;

         (xl)    3–Fluoromethcathinone;

         (xli)    4–Fluoromethcathinone;

         (xlii)       Synthetic cannabinoids as follows:

               (A) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
some trade or other names: HU-210;

               (B) Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-
6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-
tetrahydrobenzo[c]chromen-1-ol; some trade or other names: HU-
211;

               (C) Any compound structurally derived from 3-(1-
napthoyl)indole, 1H-indol-3-yl-(1-naphthyl)methane, 3-(1-
napthoyl)pyrrole, 3-(phenylacetyl)indole, 3-(benzoyl)indole or
naphthylideneindene by substitution at the nitrogen atom of the
indole ring, pyrrole ring or 3-position of the indene ring by
alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-
(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl,
whether or not further substituted in the indole ring, pyrrole
ring or indene ring to any extent, and whether or not
substituted in the naphthyl or phenyl ring to any extent;

                (D)    Repealed By Laws 2012, Ch. 29, § 2.

               (E) Any compound containing a 2-(3-
hydroxycyclohexyl)phenol structure with substitution at the 5-
position of the phenolic ring by an alkyl, haloalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-
piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or
not substituted in the cyclohexyl ring to any extent;
               (F) 2,3-Dihydro-5-methyl-3-(4-
morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-
naphthalenylmethanone; some trade or other names: WIN 55,212-2;

               (G) [(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone]; other names: XLR-11;

               (H) [(1-pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropyl)methanone]; other names: UR-144;

               (J) 1-pentyl-8-quinolinyl ester-1H-indole-3-
carboxylic acid; other names: PB-22;

               (K) 1-(5-fluoropentyl)-8-quinolinyl ester-1H-
indole-3-carboxylic acid; other names: 5F-PB-22;

               (M) 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-
indazole-3-carboxamide; other names: AKB48;

               (N) N-((3s,5s,7s)-adamantan-1-yl)-1-(5-
fluoropentyl)1H-indazole-3-carboxamide; other names: 5F-AKB48;

               (O) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-
fluorobenzyl)-1H-indazole-3-carboxamide; other names: AB-
FUBINACA;

               (P) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-
pentyl-1H-indazole-3-carboxamide; other names: ADB-PINACA;

               (Q) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-
pentyl-1H-indazole-3-carboxamide; other names: AB-PINACA;

               (R) N-(1-amino-3,3-dimethyl-1-oxobutan-2yl)-1-
(5-fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-ADB-
PINACA;

               (S) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-
fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-AB-
PINACA;

               (T) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cycl
ohexylmethyl)-1H-indazole-3-carboxamide; other names: AB–
CHMINACA;

               (U) [1-(5-fluoropentyl)-1H-indazol-3-yl](naphtha
len-1-yl)methanone; other names: THJ–2201;
               (W) 1-(cyclohexylmethyl)-1H-indole-3-carboxylic
acid 8-quinolinyl ester; other names: BB-22.

          (xliii) 2-(2,5-dimethoxy-4-ethylphenyl)ethanamine;
other names: 2C-E;

          (xliv) 2-(2,5-dimethoxy-4-methylphenyl)ethanamine;
other names: 2C-D;

          (xlv) 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine;
other names: 2C-C;

          (xlvi) 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine;
other names: 2C-I;

          (xlvii) 2-[4-(ethylthio)-2,5-
dimethoxyphenyl]ethanamine; other names: 2C-T-2;

          (xlviii) 2-[4-(isopropylthio)-2,5-
dimethoxyphenyl]ethanamine; other names: 2C-T-4;

          (xlix)   2-(2,5-dimethoxyphenyl)ethanamine; other
names: 2C-H;

          (l)   2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine; other
names: 2C-N;

          (li) 2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine;
other names: 2C-P;

          (lii) 4-bromo-2,5-dimethoxy-N-[(2-
methoxyphenyl)methyl]-benzeneethanamine; other names: 25B-NBOMe;

          (liii) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-
methoxybenzyl)ethanamine; other names: 25C-NBOMe or 2C-C-NBOMe;

          (liv) 4-iodo-2,5-dimethoxy-N-[(2-
methoxyphenyl)methyl]-benzeneethanamine; other names: 25I-NBOMe;

          (lv) 3,4-methylenedioxy-N-ethylcathinone; (other
names: ethylone).
Wyo. Stat. 35-7-1018(a), (c) · Schedule III; depressantsOFFICIAL
Instrument
Schedule III; depressants
Source
https://wyoleg.gov/statutes/compress/title35.pdf
Retrieved
2026-10-31
Fingerprint
4a14bd76c15a0d38
35-7-1018.   Substances included in Schedule III.

     (a) The controlled substances listed in this section are
included in Schedule III. Schedule III shall consist of the
drugs and other substances by whatever official name, common or
usual name, chemical name or brand name designated, listed in
this section.
(c) Depressants.-Unless specifically excepted or listed in
another schedule, any material, compound, mixture or preparation
which contains any quantity of the following substances having a
depressant effect on the central nervous system:

          (i) Any compound, mixture or preparation containing
any of the following or any salt thereof, and one (1) or more
other active medicinal ingredient not listed in any schedule:

                (A)    Amobarbital;

                (B)    Secobarbital;

                (C)    Pentobarbital.

          (ii) Any suppository dosage form containing any of
the following or any salt thereof, and approved by the food and
drug administration for marketing only as a suppository:

                (A)    Amobarbital;

                (B)    Secobarbital;

                (C)    Pentobarbital.

          (iii) Any substance which contains any quantity of a
derivative of barbituric acid or any salt thereof;

         (iv)    Chorhexadol;

         (v)    Repealed By Laws 1997, ch. 151, § 2.

         (vi)    Lysergic acid;

         (vii)    Lysergic acid amide;

         (viii)       Methyprylon;

         (ix)    Sulfondiethylmethane;

         (x)    Sulfonethylmethane;

         (xi)    Sulfonmethane;

          (xii) Tiletamine and zolazepam or any salt thereof;
some trade or other names for a tiletamine-zolazepam combination
product: telazol; some trade or other names for tiletamine: 2-
(ethylamino)-2-(2-thienyl)-cyclohexanone; some trade or other
names for zolazepam: 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-
trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,
flupyrazapon;

          (xiii) Ketamine, its salts, isomers and salts of
isomers (some other names for ketamine include (±)-2-(2-
chlorophenyl)-2-(methylamino)-cyclohexanone);

          (xiv) Any drug product containing gamma hydoxybutyric
acid, its salts, isomers and salts of isomers, for which an
application is approved under section 505 of the federal Food,
Drug and Cosmetic Act.
Wyo. Stat. Sec. 35-7-1014(d) (Schedule I, hallucinogenic substances) · Schedule I, hallucinogenic substancesOFFICIAL
Instrument
Schedule I, hallucinogenic substances
Source
https://wyoleg.gov/statutes/compress/title35.pdf
Retrieved
2026-10-28
Fingerprint
c00df93bcbc014a1
(d)  Hallucinogenic substances.-Unless specifically
excepted or unless listed in another schedule, any material,
compound, mixture or preparation which contains any quantity of
the following hallucinogenic substances, their salts, isomers
and salts of isomers whenever the existence of these salts,
isomers and salts of isomers is possible within the specific
chemical designation (for purposes of this paragraph only, the
term "isomer" includes the optical, position and geometric
isomers):

(i)  4-bromo-2, 5-dimethoxyamphetamine; some trade or

other names:   4-bromo-2,
5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2, 5-DMA;

(ii)  2, 5-dimethoxyamphetamine; some trade or other

names:   2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA;

(iii)  4-methoxyamphetamine; some trade or other

names:   4-methoxy-alpha-methylphenethylamine;
paramethoxy-amphetamine; PMA;

(iv)  5-methoxy-3,4-methylenedioxy amphetamine;

(v)  4-methyl-2, 5-dimethoxyamphetamine; some trade

and other names:
4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; “DOM”; and
“STP”;

(vi)  3,4-methylenedioxy amphetamine;

(vii)  3,4,5-trimethoxy amphetamine;

(viii)  Bufotenine; some trade and other names:

3-(beta-dimethy-laminoethyl)-5-hydroxyindole;
3-(2-dimethylaminoethyl)-5-indolol; N,N-dimethylserotonin;
5-hydroxy-N, N-dimethyltryptamine; mappine;

(ix)  Diethyltryptamine; some trade and other names:

N,N-diethyltryptamine; DET;

(x)  Dimethyltryptamine; some trade or other names:

DMT;

(xi)  Ibogaine; some trade and other names:

7-ethyl-6,6 beta, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6,
9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b] indole;
tabernanthe iboga;

(xii)  Lysergic acid diethylamide;

(xiii)  Marihuana;

(xiv)  Mescaline;

(xv)  Parahexyl; some  trade or other names;

3-hexyl-1-hydroxy 7, 8, 9, 10-tetrahydro-6, 6,
9-trimethyl-6H-dibenzo [b,d] pyran; synhexyl;

(xvi)  Peyote; meaning all parts of the plant

presently classified botanically as Lophophora Williamsii
Lemaire, whether growing or not, the seeds thereof, any extract
from any part of such plant, and every compound, manufacture,
salts, derivative, mixture, or preparation of such plant, its
seeds or extracts;

(xvii)  N-ethyl-3-piperidyl benzilate;

(xviii)  N-methyl-3-piperidyl benzilate;

(xix)  Psilocybin;

(xx)  Psilocyn;

(xxi)  Tetrahydrocannabinols; naturally occurring or
synthetic equivalents of the substances contained in the plant
or in the resinous extractives of Cannabis, sp. and/or naturally
occurring or synthetic substances, derivatives and their isomers
with similar chemical structure and pharmacological activity
such as the following: delta  1 cis or trans
tetrahydrocannabinol and their optical isomers; delta 6 cis or
trans tetrahydrocannabinol and their optical isomers; delta 8
cis or trans tetrahydrocannabinol and their optical isomers;
delta to the 3, 4 cis or trans tetrahydrocannabinol and its
optical isomers. Since nomenclature of these substances is not
internationally standardized, compounds of these structures,
regardless of numerical designation of atomic positions are
covered;

(xxii)  Ethylamine analog of phencyclidine; some trade

or other names:   N-ethyl-1-phenylcyclohexylamine,
(1-phenylcyclohexyl) ethylamine, N-(1 phenylcyclohexyl)
ethylamine, cyclohexamine, PCE;

(xxiii)  Pyrrolidine analog of phencyclidine; some

trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy,
PHP;

(xxiv)  Thiophene analog of phencyclidine; some trade

or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine,
2-thienyl analog of phencyclidine, TPCP, TCP;

(xxv)  Alpha-ethyltryptamine; some trade or other

names: etryptamine; Monase; A-ethyl-1H-indole-3-ethanamine; 3-
(2-aminobutyl) indole; --ET; and AET;

(xxvi)  4-Bromo-2,5-dimethoxyphenethylamine; some

trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-
aminoethane; alpha-desmethyl DOB; 2C-B, nexus;

(xxvii)  2,5-Dimethoxy-4-ethylamphetamine; some trade

or other names: DOET;

(xxviii)  3,4-Methylenedioxymethamphetamine (MDMA);

(xxix)  3,4-Methylenedioxy-N-ethylamphetamine (also

known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine,
N-ethyl MDA, MDE, MDEA);

(xxx)  N-hydroxy-3,4-methylenedioxyamphetamine (also

known as N-hydroxy-alpha-methyl-
3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA);

(xxxi)  1-[1-(2-thienyl)cyclohexyl]pyrrolidine; some

other names: TCPy;

(xxxii)  2,5-dimethoxy-4-(n)-propylthiophenethylamine

(other name:  2C-T-7), its optical isomers, salts and salts of
isomers;

(xxxiii)  Alpha-methyltryptamine; (other name: AMT);

(xxxiv)  5-methoxy-N,N-diisopropyltryptamine; (other

name: 5-MeO-DIPT), its isomers, salts and salts of isomers;

(xxxv)  Salvinorin A;

(xxxvi)  3,4-Methylenedioxymethcathinone (other names:

Methylone);

(xxxvii)  3,4–Methylenedioxypyrovalerone (MDPV);

(xxxviii)  4–Methylmethcathinone (other names

Mephedrone);

(xxxix)  3–Methoxymethcathinone;

(xl)  3–Fluoromethcathinone;

(xli)  4–Fluoromethcathinone;

(xlii)  Synthetic cannabinoids as follows:

(A)  (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-

(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
some trade or other names: HU-210;

(B)  Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-

6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-
tetrahydrobenzo[c]chromen-1-ol; some trade or other names: HU-
211;

(C)  Any compound structurally derived from 3-(1-

napthoyl)indole, 1H-indol-3-yl-(1-naphthyl)methane, 3-(1-
napthoyl)pyrrole, 3-(phenylacetyl)indole, 3-(benzoyl)indole or
naphthylideneindene by substitution at the nitrogen atom of the
indole ring, pyrrole ring or 3-position of the indene ring by
alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-
(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl,
whether or not further substituted in the indole ring, pyrrole
ring or indene ring to any extent, and whether or not
substituted in the naphthyl or phenyl ring to any extent;

(D)  Repealed By Laws 2012, Ch. 29, § 2.

(E)  Any compound containing a 2-(3-

hydroxycyclohexyl)phenol structure with substitution at the 5-
position of the phenolic ring by an alkyl, haloalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-
piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or
not substituted in the cyclohexyl ring to any extent;

(F)  2,3-Dihydro-5-methyl-3-(4-

morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-
naphthalenylmethanone; some trade or other names: WIN 55,212-2;

tetramethylcyclopropyl)methanone]; other names: XLR-11;

(G)  [(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-

tetramethylcyclopropyl)methanone]; other names: UR-144;

(H)  [(1-pentyl-1H-indol-3-yl)(2,2,3,3-

carboxylic acid; other names: PB-22;

(J)  1-pentyl-8-quinolinyl ester-1H-indole-3-

indole-3-carboxylic acid; other names: 5F-PB-22;

(K)  1-(5-fluoropentyl)-8-quinolinyl ester-1H-

indazole-3-carboxamide; other names: AKB48;

(M)  1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-

fluoropentyl)1H-indazole-3-carboxamide; other names: 5F-AKB48;

(N)  N-((3s,5s,7s)-adamantan-1-yl)-1-(5-

(O)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-

fluorobenzyl)-1H-indazole-3-carboxamide; other names: AB-
FUBINACA;

pentyl-1H-indazole-3-carboxamide; other names: ADB-PINACA;

(P)  N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-

pentyl-1H-indazole-3-carboxamide; other names: AB-PINACA;

(Q)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-

(R)  N-(1-amino-3,3-dimethyl-1-oxobutan-2yl)-1-

(5-fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-ADB-
PINACA;

(S)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-

fluoropentyl)-1H-indazole-3-carboxamide; other names: 5F-AB-
PINACA;

(T)  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cycl

ohexylmethyl)-1H-indazole-3-carboxamide; other names: AB–
CHMINACA;

len-1-yl)methanone; other names: THJ–2201;

(U)  [1-(5-fluoropentyl)-1H-indazol-3-yl](naphtha

acid 8-quinolinyl ester; other names: BB-22.

(W)  1-(cyclohexylmethyl)-1H-indole-3-carboxylic

(xliii)  2-(2,5-dimethoxy-4-ethylphenyl)ethanamine;

other names: 2C-E;

(xliv)  2-(2,5-dimethoxy-4-methylphenyl)ethanamine;

other names: 2C-D;

(xlv)  2-(4-chloro-2,5-dimethoxyphenyl)ethanamine;

other names: 2C-C;

(xlvi)  2-(4-iodo-2,5-dimethoxyphenyl)ethanamine;

other names: 2C-I;

(xlvii)  2-[4-(ethylthio)-2,5-
dimethoxyphenyl]ethanamine; other names: 2C-T-2;

(xlviii)  2-[4-(isopropylthio)-2,5-

dimethoxyphenyl]ethanamine; other names: 2C-T-4;

(xlix)  2-(2,5-dimethoxyphenyl)ethanamine; other

names: 2C-H;

(l)  2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine; other

names: 2C-N;

(li)  2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine;

other names: 2C-P;

(lii)  4-bromo-2,5-dimethoxy-N-[(2-

methoxyphenyl)methyl]-benzeneethanamine; other names: 25B-NBOMe;

(liii)  2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-

methoxybenzyl)ethanamine; other names: 25C-NBOMe or 2C-C-NBOMe;

(liv)  4-iodo-2,5-dimethoxy-N-[(2-

methoxyphenyl)methyl]-benzeneethanamine; other names: 25I-NBOMe;

(lv)  3,4-methylenedioxy-N-ethylcathinone; (other

names: ethylone).

Ketamine in neighboring states

Ketamine in 44 other states

Closest to Ketamine in Wyoming

Same framework in Wyoming

23 other compounds in Wyoming

Cite this page

Compound Analytics. “Is Ketamine Legal in Wyoming? Updated Nov 2026.” Compound Laws, https://compoundlaws.com/compounds/ketamine/wyoming/. Accessed November 13, 2026.

Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.

About · Methodology · Glossary · Changes · RSS · Data licensing · llms.txt · Sitemap